Valuation: Cardio Diagnostics Holdings, Inc.

Market Cap 4.94M 4.43M 4.07M 3.69M 6.9M 469M 7.03M 48.55M 19.49M 247M 18.55M 18.15M 778M P/E 2024
-2.94x
P/E 2025 -0.73x
Enterprise Value 527K 472K 434K 394K 736K 50.07M 750K 5.18M 2.08M 26.34M 1.98M 1.94M 83.06M EV / Sales 2024
866,313,328x
EV / Sales 2025 35,992,378x
Free-Float
91.69%
Yield 2024 *
-
Yield 2025 -

Last Transcript: Cardio Diagnostics Holdings, Inc.

1 day-4.57%
1 week-1.18%
1 month-12.11%
3 months+7.05%
6 months-6.70%
Current year-38.38%
1 week 1.67
Extreme 1.67
1.78
1 month 1.55
Extreme 1.55
2.23
Current year 0.97
Extreme 0.97
7.91
1 year 0.97
Extreme 0.97
7.91
3 years 0.97
Extreme 0.97
106.8
5 years 0.97
Extreme 0.97
307.5
10 years 0.97
Extreme 0.97
307.5
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 64 2016-12-31
Chief Executive Officer 38 2016-12-31
Director of Finance/CFO 61 2021-02-28
Director TitleAgeSince
Director/Board Member 38 2016-12-31
Director/Board Member 64 2016-12-31
Chairman 54 2022-10-24
Date Insider Type Main position Quantity % Market Cap. Importance
9/30/26 Free

Director

3,286 0.1110%
9/30/26 Free

Director

3,286 0.1110%
9/30/26 Free

Director

3,286 0.1110%
Change 5-day change 1-year change 3-year change Capi.($)
-4.57%-1.18%-58.66%-81.54% 4.94M
-0.62%-1.87%+42.87%+64.15% 63.77B
+0.35%+3.20%+14.40%+81.76% 56.37B
+0.53%+1.96%+16.24%+103.35% 54.62B
-2.81%-4.31%+23.50%+47.83% 44.06B
-0.33%-1.93%+19.28%+98.80% 42.11B
+0.55%+2.31%+225.14%+866.21% 41B
+3.27%+47.96%+112.84%+96.58% 34.92B
+1.22%-1.44%+14.57%+46.95% 32.82B
+0.89%+20.55%-40.62%+349.24% 24.7B
Average -0.15%+6.67%+36.95%+167.33% 39.43B
Weighted average by Cap. +0.18%+5.44%+47.99%+176.67%

Financials

2024 2025
Net sales 0.03 0.03 0.03 0.03 0.05 3.31 0.05 0.34 0.14 1.74 0.13 0.13 5.5 0.01 0.01 0.01 0.01 0.02 1.41 0.02 0.15 0.06 0.74 0.06 0.05 2.34
Net income -8.38M -7.51M -6.91M -6.26M -11.7M -796M -11.92M -82.36M -33.06M -419M -31.46M -30.79M -1.32B -6.5M -5.82M -5.35M -4.85M -9.07M -617M -9.24M -63.84M -25.63M -325M -24.39M -23.87M -1.02B
Net Debt -6.86M -6.14M -5.65M -5.12M -9.57M -651M -9.75M -67.37M -27.04M -343M -25.74M -25.19M -1.08B -4.42M -3.95M -3.64M -3.3M -6.16M -419M -6.28M -43.37M -17.41M -221M -16.57M -16.22M -695M
Projected Income Statement - Annual - Cardio Diagnostics Holdings, Inc.
Logo Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
Employees
-
Date Price Change Volume
26-10-30 US$1.670 -4.57% 12,035
26-10-29 US$1.750 +2.94% 5,714
26-10-28 US$1.700 -.--% 9,163
26-10-27 US$1.700 -1.16% 9,057
26-10-26 US$1.720 +1.78% 5,904

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Cardio Diagnostics Holdings, Inc.
  1. Stock Market
  2. Stocks
  3. CDIO Stock